Recombinant DNA News and Research

RSS
Recombinant DNA is a variety of techniques that molecular biologists use to manipulate DNA molecules to study the expression of a gene.
Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

2D-NMR could be a powerful complementary technique for assessing biosimilarity of protein drugs

2D-NMR could be a powerful complementary technique for assessing biosimilarity of protein drugs

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Kanuma approved as first treatment for patients with LAL deficiency

Kanuma approved as first treatment for patients with LAL deficiency

FDA takes important steps regarding genetically engineered plants and animals intended for food

FDA takes important steps regarding genetically engineered plants and animals intended for food

Researchers devise system to accelerate the process of making life-saving vaccines

Researchers devise system to accelerate the process of making life-saving vaccines

Nucala (mepolizumab) approved for treatment of asthma patients

Nucala (mepolizumab) approved for treatment of asthma patients

Glide Technologies, Cilian collaborate to develop solid dose formulation of recombinant influenza vaccine

Glide Technologies, Cilian collaborate to develop solid dose formulation of recombinant influenza vaccine

TGen and Baylor partnership set to increase treatment options for cancer patients

TGen and Baylor partnership set to increase treatment options for cancer patients

NAS, NAM launch major initiative to guide decision making on human gene-editing research

NAS, NAM launch major initiative to guide decision making on human gene-editing research

Scientists develop potential new therapy based on cow's immune molecules for hormone deficiencies

Scientists develop potential new therapy based on cow's immune molecules for hormone deficiencies

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

WIRB-Copernicus Group acquires Alliance Biosciences

WIRB-Copernicus Group acquires Alliance Biosciences

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

GenVec's revenues decrease 61% to $3.7M in fourth quarter 2013

GenVec's revenues decrease 61% to $3.7M in fourth quarter 2013

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

VaxInnate starts Phase 1 clinical trial to evaluate VAX2012Q for prevention of seasonal influenza

VaxInnate starts Phase 1 clinical trial to evaluate VAX2012Q for prevention of seasonal influenza

UCSF inaugurates new endowment of PhD education programs in basic sciences

UCSF inaugurates new endowment of PhD education programs in basic sciences